| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Radiology, Brigham and Women's Hospital and Harvard Medical
School, 75 Francis St., Boston, MA 02115.
2 Department of Pathology, Brigham and Women's Hospital and Harvard Medical
School, Boston, MA 02115.
3 Department of Radiology, University of North Carolina at Chapel Hill, 2016 Old
Clinic Building, Campus Box 7510, Chapel Hill, NC 27599-7510.
OBJECTIVE. The purpose of our retrospective study was to evaluate the sensitivity and negative predictive value of percutaneous biopsy of renal masses stratified by clinical setting and the size of the mass.
MATERIALS AND METHODS. We categorized 115 consecutive percutaneous biopsies of renal masses in 113 patients into four clinical settings and three groups of mass sizes. The sensitivity and negative predictive value were computed (with 95% confidence intervals [CI]) for each clinical setting and for each size group.
RESULTS. For all procedures (n = 115), the sensitivity and negative predictive value were 90% (95% CI, 81-95%) and 64% (95% CI, 44-81%), respectively. For patients with a known malignancy who presented with a renal mass (n = 55), the sensitivity and negative predictive value were 90% (95% CI, 78-96%) and 38% (95% CI, 10-74%), respectively. For patients with no known malignancy and suspected unresectable tumor (n = 36), the sensitivity and negative predictive value were 92% (95% CI, 76-98%) and 0%, respectively. For patients with no known malignancy who presented with a cystic mass (n = 16), the sensitivity and negative predictive value were 33% (95% CI, 2-87%) and 87% (95% CI, 58-98%), respectively. For patients who were not surgical candidates with a renal cell carcinoma (n = 8) that was thought to be resectable, both the sensitivity and negative predictive value were 100%. For masses 3 cm and less (n = 31), the sensitivity and negative predictive value were 84% (95% CI, 63-95%) and 60% (95% CI, 27-86%), respectively. For masses between 4 and 6 cm (n = 42), the sensitivity and negative predictive value were 97% (95% CI, 83-100%) and 89% (95% CI, 51-99%), respectively. For masses greater than 6 cm (n = 42), the sensitivity and negative predictive value were 87% (95% CI, 71-95%) and 44% (95% CI, 15-77%), respectively.
CONCLUSION. Percutaneous renal mass biopsy has a high sensitivity in
three clinical settings: patients with a known malignancy, patients with no
known malignancy and suspected unresectable tumor, and nonsurgical patients
with a mass suspected to be a resectable renal cell carcinoma. Negative
results in small (
3 cm) and large (> 6 cm) masses should be viewed
with caution.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. G. Silverman, G. M. Israel, B. R. Herts, and J. P. Richie Management of the Incidental Renal Mass Radiology, October 1, 2008; 249(1): 16 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Israel and M. A. Bosniak Pitfalls in Renal Mass Evaluation and How to Avoid Them RadioGraphics, September 1, 2008; 28(5): 1325 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Signoretti, G. Bratslavsky, F. M. Waldman, V. E. Reuter, J. Haaga, M. Merino, G. V. Thomas, M. R. Pins, T. Libermann, J. Gillespie, et al. Tissue-Based Research in Kidney Cancer: Current Challenges and Future Directions Clin. Cancer Res., June 15, 2008; 14(12): 3699 - 3705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Hatfield, R. A. Beres, S. S. Sane, and G. X. Zaleski Percutaneous Imaging-Guided Solid Organ Core Needle Biopsy: Coaxial Versus Noncoaxial Method Am. J. Roentgenol., February 1, 2008; 190(2): 413 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Silverman, K. J. Mortele, K. Tuncali, M. Jinzaki, and E. S. Cibas Hyperattenuating Renal Masses: Etiologies, Pathogenesis, and Imaging Evaluation RadioGraphics, July 1, 2007; 27(4): 1131 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Heilbrun, R. J. Zagoria, A. J. Garvin, M. C. Hall, K. Krehbiel, A. Southwick, and P. E. Clark CT-Guided Biopsy for the Diagnosis of Renal Tumors Before Treatment with Percutaneous Ablation Am. J. Roentgenol., June 1, 2007; 188(6): 1500 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Beland, W. W. Mayo-Smith, D. E. Dupuy, J. J. Cronan, and R. A. DeLellis Diagnostic Yield of 58 Consecutive Imaging-Guided Biopsies of Solid Renal Masses: Should We Biopsy All That Are Indeterminate? Am. J. Roentgenol., March 1, 2007; 188(3): 792 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Silverman, Y. U. Gan, K. J. Mortele, K. Tuncali, and E. S. Cibas Renal Masses in the Adult Patient: The Role of Percutaneous Biopsy Radiology, July 1, 2006; 240(1): 6 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sheth, S. Ali, and E. Fishman Imaging of renal lymphoma: patterns of disease with pathologic correlation. RadioGraphics, July 1, 2006; 26(4): 1151 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Israel and M. A. Bosniak How I Do It: Evaluating Renal Masses Radiology, August 1, 2005; 236(2): 441 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tuncali, E. vanSonnenberg, S. Shankar, K. J. Mortele, E. S. Cibas, and S. G. Silverman Evaluation of Patients Referred for Percutaneous Ablation of Renal Tumors: Importance of a Preprocedural Diagnosis Am. J. Roentgenol., September 1, 2004; 183(3): 575 - 582. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
